PF-04691502, a PI3K/mTOR Dual Inhibitor, Ameliorates AD-like Pathology in a Mouse Model of AD
Marika Lanza(University of Messina), Emanuela Esposito(University of Messina)
Cited by 0
Related Papers
Antiinflammatory Activity of Melatonin in Central Nervous System
|Current Neuropharmacology|2010|406
Neuroprotective Activities of Palmitoylethanolamide in an Animal Model of Parkinson's Disease
|PLoS ONE|2012|144
Marine Algae and Deriving Biomolecules for the Management of Inflammatory Bowel Diseases: Potential Clinical Therapeutics to Decrease Gut Inflammatory and Oxidative Stress Markers?
|Marine Drugs|2024|17